共 14 条
- [4] Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT)[J] . Takenori Yamaguchi,Etsuro Mori,Kazuo Minematsu,Jyoji Nakagawara,Kazuo Hashi,Isamu Saito,Yukito Shinohara.Stroke . 2006 (7)
- [5] Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials[J] . Stroke . 2006 (3)
- [7] Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials[J] . Hacke Werner,Donnan Geoffrey,Fieschi Cesare,Kaste Markku,von Kummer Rüdiger,Broderick Joseph P,Brott Thomas,Frankel Michael,Grotta James C,Haley E Clarke,Kwiatkowski Thomas,Levine Steven R,Lewandowski Chris,Lu Mei,Lyden Patrick,Marler John R,Patel Suresh,Tilley Barbara C,Albers Gregory,Bluhmki Erich,Wilhelm Manfred,Hamilton Scott.The Lancet . 2004 (9411)
- [9] GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats[J] . V.M. Goettl,T.A. Wemlinger,A.-M. Duchemin,N.H. Neff,M. Hadjiconstantinou.Neuroscience . 1999 (3)
- [10] GM1 Produces Attenuation of Short-Term Memory Deficits in Hebb–Williams Maze Performance after Unilateral Entorhinal Cortex Lesions[J] . Marylou M Glasier,L.Scott Janis,Maria I Goncalves,Donald G Stein.Physiology & Behavior . 1999 (3)